Ligand Pharmaceuticals Incorporated target price raised to $357 from $345 by RBC
LGND•RBC raised its target price for Ligand Pharmaceuticals Incorporated to $357 from $345.
LGND•LGND•LGND•RBC raised its target price for Ligand Pharmaceuticals Incorporated to $357 from $345.
